Experts Cull Financial Lessons From 'Game of Thrones'
15 Natural Cleaning Products You Can Make at Home
Money Experts Share the 9 Best Ways to Stretch $10
The Next Big Automotive Boom: Super-Luxury SUVs
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.